These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 224885)
1. Anti-herpes activity of the adenine arabinoside analog, 2'-azido-2'-deoxy-beta-D-arabinofuranosyladenine. Cermak-Mörth CM; Christian R; Unger FM Biochem Pharmacol; 1979 Jul; 28(13):2105-8. PubMed ID: 224885 [No Abstract] [Full Text] [Related]
2. Prodrugs of 9-(beta-D-arabinofuranosyl)adenine 2. Synthesis and evaluation of a number of 2',3'- and 3',5'-di-O-acyl derivatives. Baker DC; Haskell TH; Putt SR; Sloan BJ J Med Chem; 1979 Mar; 22(3):273-9. PubMed ID: 218013 [TBL] [Abstract][Full Text] [Related]
3. 2-Substituted derivatives of 9-alpha-D-arabinofuranosyladenine and 9-alpha-D-arabinofuranosyl-8-azaadenine. Montgomery JA; Shortnacy AT; Arnett G; Shannon WM J Med Chem; 1977 Mar; 20(3):401-4. PubMed ID: 191611 [TBL] [Abstract][Full Text] [Related]
4. Antiherpesvirus activity in human sera and urines after administration of adenine arabinoside: in vitro and in vivo synergy of adenine arabinoside and arabinosylhypoxanthine in combination. Champney KJ; Lauter CB; Bailey EJ; Lerner AM J Clin Invest; 1978 Dec; 62(6):1142-53. PubMed ID: 219024 [TBL] [Abstract][Full Text] [Related]
5. Cytotoxic activity of the adenine arabinoside analogs, 2'-azido- and 2'-amino-2'-deoxy-beta-D-arabinofuranosyladenine. Lee SH; Unger FM; Christian R; Sartorelli AC Biochem Pharmacol; 1979 Apr; 28(7):1267-9. PubMed ID: 444286 [No Abstract] [Full Text] [Related]
6. Activity of (+)-cyclaradine (Sch 31172) against herpes simplex virus in vitro and in vivo. Schwartz J; Ostrander M; Butkiewicz NJ; Lieberman M; Lin C; Lim J; Miller GH Antimicrob Agents Chemother; 1987 Jan; 31(1):21-6. PubMed ID: 3032089 [TBL] [Abstract][Full Text] [Related]
7. In vitro system for studying the efficacy of antiviral agents in preventing the reactivation of latent herpes simplex virus. Wohlenberg C; Openshaw H; Notkins AL Antimicrob Agents Chemother; 1979 Apr; 15(4):625-7. PubMed ID: 223499 [TBL] [Abstract][Full Text] [Related]
8. Differential sensitivity of herpes simplex virus types 1 and 2 to human interferon: antiviral effects of interferon plus 9-beta-D-arabinofuranosyladenine. Lerner AM; Bailey EJ J Infect Dis; 1976 Oct; 134(4):400-4. PubMed ID: 185303 [TBL] [Abstract][Full Text] [Related]
9. Carbocyclic arabinosyladenine, an adenosine deaminase resistant antiviral agent. Vince R; Daluge S J Med Chem; 1977 Apr; 20(4):612-3. PubMed ID: 191615 [No Abstract] [Full Text] [Related]
10. Erythro-9-(2-hydroxy-3-nonyl) Adenine alone and in combination with 9-beta-D-arabinofuranosyladenine in treatment of systemic herpesvirus infections in mice. Shannon WM; Arnett G; Schabel FM; North TW; Cohen SS Antimicrob Agents Chemother; 1980 Oct; 18(4):598-603. PubMed ID: 6255863 [TBL] [Abstract][Full Text] [Related]
11. Clinical application of adenine arabinoside. Keeney RE; Buchanan RA Ann N Y Acad Sci; 1975 Aug; 255():185-9. PubMed ID: 171991 [No Abstract] [Full Text] [Related]
12. Antiviral activity in the rabbit cornea of adenine arabinoside, Ara-A 5' monophosphate, and hypoxanthine arabinoside; and interactions with adenosine deaminase inhibitor. Falcon MG; Jones BR J Gen Virol; 1977 Jul; 36(1):199-202. PubMed ID: 196039 [TBL] [Abstract][Full Text] [Related]
13. Synthesis of N6- or 8-substituted 9-(beta-D-arabinofuranosyl)-adenines and their antiviral activities against herpes simplex and vaccinia viruses. Kaneko M; Kimura M; Nishimura T; Shimizu B Chem Pharm Bull (Tokyo); 1977 Oct; 25(10):2482-9. PubMed ID: 201386 [No Abstract] [Full Text] [Related]
14. [Comparative study of antiherpetic effect of 9-beta-D-xylofuranosyl- adenine and 9-beta-D-arabinofuranosyladenine and their inhibition of defective herpes simplex type 1 virus in a cell culture]. Shobukhov VM; Kiseleva NV; Pravdina NF; Kaz'mina EM; Galegov GA Vopr Virusol; 1989; 34(6):741-4. PubMed ID: 2561237 [No Abstract] [Full Text] [Related]
15. The antiviral activity of 9-beta-D-arabinofuranosyladenine is enhanced by the 2',3'-dideoxyriboside, the 2',3'-didehydro-2',3'-dideoxyriboside and the 3'-azido-2',3'-dideoxyriboside of 2,6-diaminopurine. Balzarini J; De Clercq E Biochem Biophys Res Commun; 1989 Feb; 159(1):61-7. PubMed ID: 2538128 [TBL] [Abstract][Full Text] [Related]
16. Variables influencing the in vitro susceptibilities of herpes simplex viruses to antiviral drugs. Marks MI Antimicrob Agents Chemother; 1974 Jul; 6(1):34-8. PubMed ID: 15828168 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of a series of 2'-O-acyl derivatives of 9-beta-D-arabinofuranosyladenine as antiherpes agents. Baker DC; Kumar SD; Waites WJ; Arnett G; Shannon WM; Higuchi WI; Lambert WJ J Med Chem; 1984 Mar; 27(3):270-4. PubMed ID: 6321734 [TBL] [Abstract][Full Text] [Related]
18. Influence of 1-dodecylazacycloheptan-2-one (Azone) on the topical therapy of cutaneous herpes simplex virus type 1 infection in hairless mice with 2',3'-di-O-acetyl-9-beta-D-arabinofuranosyladenine and 5'-O-valeryl-9-beta-D-arabinofuranosyladenine. Shannon WM; Westbrook L; Higuchi WI; Sugibayashi K; Baker DC; Kumar SD; Fox JL; Flynn GL; Ho NF; Vaidyanathan R J Pharm Sci; 1985 Nov; 74(11):1157-61. PubMed ID: 4087174 [TBL] [Abstract][Full Text] [Related]
19. [Comparative studies of anti-herpes simplex virus compounds in vitro]. Inoue S; Shiota H Nippon Ganka Gakkai Zasshi; 1982; 86(11):2113-21. PubMed ID: 6301237 [No Abstract] [Full Text] [Related]
20. Biological activities and modes of action of 9-alpha-D-arabinofuranosyladenine and 9-alpha-D-arabinofuranosyl-8-azaadenine. Bennett LL; Allan PW; Shaddix SC; Shannon WM; Arnett G; Westbrook L; Drach JC; Reinke CM Biochem Pharmacol; 1981 Aug; 30(16):2325-32. PubMed ID: 6271140 [No Abstract] [Full Text] [Related] [Next] [New Search]